wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38398440-158D8852-5BCF-428A-912B-71D0322CF787
Q38398440-158D8852-5BCF-428A-912B-71D0322CF787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38398440-158D8852-5BCF-428A-912B-71D0322CF787
ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.
P2860
Q38398440-158D8852-5BCF-428A-912B-71D0322CF787
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38398440-158D8852-5BCF-428A-912B-71D0322CF787
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7790b5aa97d97345961d1d4951371cdaa2def07
P2860
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy.